中国P站

Myocardial Revascularization; Percutaneous Coronary Intervention (PCI); Coronary Artery Bypass Grafting (CABG); Multivessel Coronary Artery Disease; Stable Angina; Left Ventricular Dysfunction; Diabetic Patients; Fractional Flow Reserve (FFR); Hybrid Coronary Revascularization (HCR); Cardiogenic Shock

Introduction

Myocardial revascularization for stable angina has been a cornerstone of cardiac care, with ongoing debate and research comparing percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). A comprehensive review critically assesses the evidence for both strategies across various patient subgroups, emphasizing patient selection, procedural outcomes, and long-term implications in the treatment of stable angina [1].

Beyond the choice of PCI or CABG, the extent of revascularization—whether complete or incomplete—is a crucial consideration, particularly in patients with multivessel coronary artery disease. A meta-analysis synthesized data from numerous randomized controlled trials, offering vital insights into the benefits and risks associated with these differing approaches, thereby helping to define optimal revascularization strategies [2].

Patients presenting with multivessel disease coupled with left ventricular dysfunction represent a high-risk cohort where revascularization decisions are particularly impactful. A systematic review and meta-analysis specifically compared the long-term outcomes of CABG versus PCI in this vulnerable group, shedding light on the profound influence of the chosen revascularization strategy on crucial metrics like mortality and major adverse cardiac events [3].

Acute Coronary Syndromes (ACS) with concomitant multivessel disease pose immediate and significant challenges. A state-of-the-art review focuses on the current evidence and clinical implications of complete revascularization in this urgent setting, meticulously discussing both the inherent benefits and the associated challenges of implementing such an aggressive revascularization approach during a critical phase of cardiac disease [4].

The presence of chronic total occlusions (CTOs) alongside multivessel coronary artery disease adds another layer of complexity to revascularization planning. An article specifically reviews the latest strategies and important considerations for managing these difficult lesions, systematically examining the distinct roles of both PCI and various surgical approaches in striving to improve patient outcomes in this intricate scenario [5].

Diabetic patients with multivessel coronary artery disease constitute a particularly high-risk population due to their elevated comorbidity burden and unique physiological responses. An updated meta-analysis critically compares the efficacy and safety profiles of PCI versus CABG in this specific demographic, providing indispensable, up-to-date insights that are vital for informed clinical decision-making tailored to diabetic patients [6].

Innovative approaches continue to emerge in the quest for superior revascularization methods. Hybrid Coronary Revascularization (HCR) is one such strategy, combining elements of both surgical and percutaneous techniques. A comprehensive meta-analysis evaluates the outcomes of HCR for multivessel coronary artery disease, meticulously comparing its overall effectiveness and its safety profile against more conventional, established revascularization strategies [7].

Optimizing revascularization decisions for intermediate coronary lesions often requires advanced physiological assessment. A thorough review delves into the existing evidence and current recommendations concerning Fractional Flow Reserve (FFR)-guided revascularization, exploring its pivotal role in guiding clinical choices and outlining future directions for physiological assessment techniques in cardiology [8].

Understanding the long-term prognosis for patients with multivessel coronary artery disease and reduced left ventricular ejection fraction is paramount for guiding treatment. A dedicated study precisely examines the long-term clinical outcomes observed following the implementation of different revascularization strategies in this patient subgroup, thereby furnishing crucial insights into their prognosis and the overall efficacy of various treatment modalities [9].

In critical scenarios like cardiogenic shock precipitated by multivessel coronary artery disease, timely and effective revascularization is often life-saving. A contemporary review highlights the critical role of revascularization in these profoundly ill patients, offering a concise summary of the most current evidence and established guidelines for achieving optimal management and improving survival rates in such dire circumstances [10].

Description

The complex landscape of myocardial revascularization for stable angina involves a detailed assessment of Percutaneous Coronary Intervention (PCI) versus Coronary Artery Bypass Grafting (CABG). A critical review meticulously evaluates patient selection criteria, procedural outcomes, and long-term implications, providing a comprehensive comparison of both strategies across various patient subgroups to inform evidence-based clinical practice [1]. The extent of revascularization is equally vital, particularly in patients with multivessel coronary artery disease. A significant meta-analysis has synthesized data from numerous randomized controlled trials, carefully evaluating the benefits and risks of complete versus incomplete revascularization, which is fundamental for guiding optimal treatment strategies [2].

For patients facing multivessel disease alongside concomitant left ventricular dysfunction, the choice of revascularization strategy carries substantial weight. A systematic review and meta-analysis distinctly compared the long-term outcomes of CABG versus PCI in this high-risk population, underscoring the profound impact on critical endpoints such as mortality and major adverse cardiac events [3]. In the context of acute coronary syndromes (ACS) with multivessel disease, a state-of-the-art review has illuminated the current evidence and clinical implications of pursuing complete revascularization, openly discussing the inherent benefits and challenges associated with this aggressive approach in acute settings [4]. Furthermore, the management of chronic total occlusions (CTOs) within multivessel coronary artery disease necessitates specialized considerations. A dedicated article systematically reviews the latest strategies and considerations, examining both PCI and surgical methods for improving patient outcomes in these intricate cases [5].

Diabetic patients with multivessel coronary artery disease represent a unique challenge due to their increased cardiovascular risk. An updated meta-analysis specifically addresses this cohort, comparing the efficacy and safety of PCI versus CABG, thereby offering crucial, updated insights essential for tailored clinical decision-making in this vulnerable group [6]. As the field progresses, innovative techniques such as Hybrid Coronary Revascularization (HCR) are gaining attention for multivessel coronary artery disease. A comprehensive meta-analysis evaluates HCR's effectiveness and safety profile in direct comparison to conventional revascularization strategies, providing valuable data for its integration into practice [7].

Optimizing interventions for intermediate coronary lesions often relies on advanced physiological assessments. A review explores the existing evidence, current recommendations, and future directions for Fractional Flow Reserve (FFR)-guided revascularization, emphasizing its crucial role in refining treatment decisions [8]. Understanding the long-term trajectory for patients with multivessel coronary artery disease and reduced left ventricular ejection fraction is also paramount. A study examines the long-term clinical outcomes following different revascularization strategies, yielding vital insights into prognosis and treatment efficacy for this specific group [9].

Lastly, the dire scenario of cardiogenic shock stemming from multivessel coronary artery disease demands immediate and informed action. A contemporary review highlights the indispensable role of revascularization in such patients, summarizing current evidence and guidelines for achieving optimal management and improved patient survival [10]. These collective studies emphasize the nuanced and patient-specific approaches required in contemporary myocardial revascularization.

Conclusion

The field of myocardial revascularization is continually evolving, with extensive research comparing various strategies for patients with coronary artery disease. Studies consistently evaluate Percutaneous Coronary Intervention (PCI) versus Coronary Artery Bypass Grafting (CABG) across diverse patient populations. Research has provided comprehensive comparisons of PCI and CABG for stable angina, focusing on patient selection, procedural outcomes, and long-term implications, including critical assessments of evidence in various subgroups. Meta-analyses have further synthesized data from multiple randomized controlled trials to assess the benefits and risks of complete versus incomplete revascularization in patients with multivessel coronary artery disease, guiding optimal strategies. Systematic reviews have delved into long-term outcomes of CABG versus PCI in patients with multivessel disease and concomitant left ventricular dysfunction, highlighting impacts on mortality and major adverse cardiac events. State-of-the-art reviews focus on complete revascularization for acute coronary syndromes with multivessel disease, detailing its benefits and challenges. Considerations for revascularization extend to patients with chronic total occlusions (CTOs) alongside multivessel coronary artery disease, exploring the roles of PCI and surgical approaches. Specific patient groups like diabetics with multivessel coronary artery disease have been examined in updated meta-analyses comparing PCI and CABG efficacy and safety, crucial for clinical decision-making. Emerging strategies like Hybrid Coronary Revascularization (HCR) for multivessel coronary artery disease are also being evaluated for effectiveness and safety against conventional methods. Fractional Flow Reserve (FFR)-guided revascularization is another area of focus, with reviews exploring its evidence, recommendations, and future in optimizing decisions for intermediate coronary lesions. Furthermore, studies assess long-term clinical outcomes following various revascularization strategies in patients with reduced left ventricular ejection fraction and multivessel disease, providing insights into prognosis. The critical role of revascularization in patients experiencing cardiogenic shock due to multivessel coronary artery disease is also addressed through contemporary reviews, summarizing evidence and guidelines for optimal management.

1. Scott DF, Joel R, Robert AO (2023) .J Am Coll Cardiol 82:1530-1544.

, ,

1. Raffaele P, Alessandro S, Andrea F (2022) .J Am Coll Cardiol 80:1851-1863.

, ,

1. Moazam A, M. AZ, Abdul H (2023) .J Clin Med 12:4371.

, ,

1. Sunil S, Sanjit SJ, Marco V (2021) .J Am Coll Cardiol 78:56-74.

, ,

1. Gerald SW, Dimitrios VA, Alfredo RG (2020) .Curr Opin Cardiol 35:367-373.

, ,

1. Chao C, Yujiao W, Zhiyuan W (2023) .J Interv Cardiol 2023:4523788.

, ,

1. Hongtao S, Chao Z, Chunlei S (2022) .J Thorac Dis 14:1619-1630.

, ,

1. Pieter AT, Bernard DB, William FF (2020) .JACC Cardiovasc Interv 13:669-684.

, ,

1. Pijus S, Jurate K, Daiva J (2023) .Diagnostics (Basel) 13:1736.

, ,

1. Hassan K, Mohamed MG, Ahmed E (2021) .Cardiovasc Revasc Med 27:110-117.

, ,